1) The GLANT Study Group:A 12-month comparison of ACE inhibitor and Ca antagonist therapy in mild to moderate essential hypertension;The GLANT Study. Hypertens Res 18:235-244, 1995
2) Julius S, et al:Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine; The VALUE randomised trial. Lancet 363:2022-2031, 2004
3) Dahlöf B, et al:Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required, versus atenolol adding bendroflumethiazide as requred, in the Anglo-Scandinavian Cardiac Outcomes. Trial-Blood Pressure Lowering Arm(ASCOT-BPLA);A multicentre randomised controlled trial. Lancet 366:895-906, 2005
4) Verdecchia P, et al:Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension 46:386-392, 2005
5) 日本高血圧学会高血圧治療ガイドライン作成委員会:高血圧治療ガイドライン2004.日本高血圧学会,2004